160 related articles for article (PubMed ID: 37629061)
21. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of the ferroptosis-related ceRNA network in irreversible pulpitis.
Xie Q; Yu H; Liu Z; Zhou B; Fang F; Qiu W; Wu H
Front Immunol; 2023; 14():1198053. PubMed ID: 37275855
[TBL] [Abstract][Full Text] [Related]
24. Pyroptosis-Related Genes as Markers for Identifying Prognosis and Microenvironment in Low-Grade Glioma.
Han J; Jing Y; Sun P
J Healthc Eng; 2023; 2023():6603151. PubMed ID: 36820395
[TBL] [Abstract][Full Text] [Related]
25. Role of ferroptosis-related genes in periodontitis based on integrated bioinformatics analysis.
Zhang S; Jin H; Da J; Zhang K; Liu L; Guo Y; Zhang W; Geng Y; Liu X; Zhang J; Jiang L; Yuan H; Wang J; Zhan Y; Li Y; Zhang B
PLoS One; 2022; 17(7):e0271202. PubMed ID: 35901060
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas.
Wang J; Peng H; Zhang G; Yan W
Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349
[TBL] [Abstract][Full Text] [Related]
27. Association of RNA-modification "writer" genes with prognosis and response to immunotherapy in patients with low-grade glioma.
Zhang L; Qu C; Shi C; Wu F; Tang Y; Li Y; Li J; Feng H; Zhong S; Yang J; Zeng X; Peng X
PLoS One; 2023; 18(1):e0279119. PubMed ID: 36649311
[TBL] [Abstract][Full Text] [Related]
28. Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma.
Huang QR; Li JW; Yan P; Jiang Q; Guo FZ; Zhao YN; Mo LG
Front Neurol; 2022; 13():861438. PubMed ID: 35832170
[TBL] [Abstract][Full Text] [Related]
29. Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer.
Zhou R; Ma HC; Liu YH; Chen X; Chang XS; Chen YD; Liu LR; Li Y; Zhu YJ; Zhang HB
Exp Biol Med (Maywood); 2022 Aug; 247(16):1447-1465. PubMed ID: 35762414
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
[TBL] [Abstract][Full Text] [Related]
31. Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma.
Sun F; Lv H; Feng B; Sun J; Zhang L; Dong B
Aging (Albany NY); 2023 Jul; 15(13):6264-6291. PubMed ID: 37405952
[TBL] [Abstract][Full Text] [Related]
32. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
[TBL] [Abstract][Full Text] [Related]
33. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
34. Ferroptosis heterogeneity within the tumor microenvironment revealed a genetic blueprint of breast cancer.
Qiu Z; Deng C; Zhou F; Chen Y; Chen X; Liu X; Ye C; Jin N
Environ Toxicol; 2024 May; 39(5):2741-2752. PubMed ID: 38251953
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
[TBL] [Abstract][Full Text] [Related]
36. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
Front Immunol; 2022; 13():982033. PubMed ID: 36052073
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
Zhao J; Liu Z; Zheng X; Gao H; Li L
Front Genet; 2021; 12():753680. PubMed ID: 34819946
[No Abstract] [Full Text] [Related]
38. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y
Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057
[TBL] [Abstract][Full Text] [Related]
39. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
[No Abstract] [Full Text] [Related]
40. A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
Luo C; Wang S; Shan W; Liao W; Zhang S; Wang Y; Xin Q; Yang T; Hu S; Xie W; Xu N; Zhang Y
Front Immunol; 2022; 13():909189. PubMed ID: 35769464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
